The .03 trigger for treatment all started from a study Tall Allan related to us, which I read. The study was strictly relevant only to patients that were classified t3a post op. My memory fails me if it was t3a or more.
This is quite incorrect. That study was among anyone with adverse pathology - positive margins or
Logo, I almost never read any of your posts because I never learned to speak Gibberish, and I figure if you have anything valuable to say, someone else, who writes actual English, will say it. But your use of my name caught my eye. Please don't misinform people using me as a source - Thanks.